Olympus Gains FDA Clearance for POWERSEAL Open Device
WESTBOROUGH, MASSACHUSETTS, April 28, 2026 Olympus Corporation has received FDA 510(k) clearance for its latest innovation, the POWERSEALâ„¢ Open...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
WESTBOROUGH, MASSACHUSETTS, April 28, 2026 Olympus Corporation has received FDA 510(k) clearance for its latest innovation, the POWERSEALâ„¢ Open...
PITTSBURGH, Pa., April 17, 2026 Xodus Medical, Inc. announced the launch of its Hot Pink Pad®, following FDA 510(k)...
